1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for
Study
1.2.3.
Key Market
Segmentations
2. Research Methodology
2.1. Objective
of the Study
2.2. Baseline
Methodology
2.3. Key
Industry Partners
2.4. Major
Association and Secondary Sources
2.5. Forecasting
Methodology
2.6. Data
Triangulation & Validations
2.7. Assumptions
and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
Global Opisthorchiasis Treatment Market
Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Medications v/s Surgery)
5.2.1.1.
By Medications (Antibiotics,
Anthelmintics, Others)
5.2.2. By Diagnostic Procedure (Cholangiography, MRI,
Ultrasonography, CT scan, Others)
5.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly,
Weight loss, Tachycardia, Others)
5.2.4. By End User (Hospitals & Clinics, Ambulatory Care
Centers, Others)
5.2.5. By Region
5.2.6. By Company (2022)
5.3. Market Map
6.
North America Opisthorchiasis
Treatment Market Outlook
6.1.
Market Size &
Forecast
6.1.1.
By Value
6.2.
Market Share &
Forecast
6.2.1.
By Type
6.2.2.
By Diagnostic
Procedure
6.2.3.
By Symptom
6.2.4.
By End User
6.2.5.
By Country
6.3. North America: Country Analysis
6.3.1. United States Opisthorchiasis Treatment
Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Type
6.3.1.2.2.
By Diagnostic
Procedure
6.3.1.2.3.
By Symptom
6.3.1.2.4.
By End User
6.3.2. Canada Opisthorchiasis Treatment Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Type
6.3.2.2.2.
By Diagnostic
Procedure
6.3.2.2.3.
By Symptom
6.3.2.2.4.
By End User
6.3.3. Mexico Opisthorchiasis Treatment Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Type
6.3.3.2.2.
By Diagnostic
Procedure
6.3.3.2.3.
By Symptom
6.3.3.2.4.
By End User
7.
Europe Opisthorchiasis
Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Diagnostic Procedure
7.2.3. By Symptom
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Opisthorchiasis Treatment Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Type
7.3.1.2.2.
By Diagnostic
Procedure
7.3.1.2.3.
By Symptom
7.3.1.2.4.
By End User
7.3.2. United Kingdom Opisthorchiasis Treatment
Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Type
7.3.2.2.2.
By Diagnostic
Procedure
7.3.2.2.3.
By Symptom
7.3.2.2.4.
By End User
7.3.3. Italy Opisthorchiasis Treatment Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecasty
7.3.3.2.1.
By Type
7.3.3.2.2.
By Diagnostic
Procedure
7.3.3.2.3.
By Symptom
7.3.3.2.4.
By End User
7.3.4. France Opisthorchiasis Treatment Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Type
7.3.4.2.2.
By Diagnostic
Procedure
7.3.4.2.3.
By Symptom
7.3.4.2.4.
By End User
7.3.5. Spain Opisthorchiasis Treatment Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Type
7.3.5.2.2.
By Diagnostic
Procedure
7.3.5.2.3.
By Symptom
7.3.5.2.4.
By End User
8.
Asia-Pacific Opisthorchiasis
Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Diagnostic Procedure
8.2.3. By Symptom
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Opisthorchiasis Treatment Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type
8.3.1.2.2.
By Diagnostic
Procedure
8.3.1.2.3.
By Symptom
8.3.1.2.4.
By End User
8.3.2. India Opisthorchiasis Treatment Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type
8.3.2.2.2.
By Diagnostic
Procedure
8.3.2.2.3.
By Symptom
8.3.2.2.4.
By End User
8.3.3. Japan Opisthorchiasis Treatment Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type
8.3.3.2.2.
By Diagnostic
Procedure
8.3.3.2.3.
By Symptom
8.3.3.2.4.
By End User
8.3.4. South Korea Opisthorchiasis Treatment Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Type
8.3.4.2.2.
By Diagnostic
Procedure
8.3.4.2.3.
By Symptom
8.3.4.2.4.
By End User
8.3.5. Australia Opisthorchiasis Treatment Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Type
8.3.5.2.2.
By Diagnostic Procedure
8.3.5.2.3.
By Symptom
8.3.5.2.4.
By End User
9.
South America Opisthorchiasis
Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Diagnostic Procedure
9.2.3. By Symptom
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Opisthorchiasis Treatment Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type
9.3.1.2.2.
By Diagnostic
Procedure
9.3.1.2.3.
By Symptom
9.3.1.2.4.
By End User
9.3.2. Argentina Opisthorchiasis Treatment Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type
9.3.2.2.2.
By Diagnostic
Procedure
9.3.2.2.3.
By Symptom
9.3.2.2.4.
By End User
9.3.3. Colombia Opisthorchiasis Treatment Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type
9.3.3.2.2.
By Diagnostic
Procedure
9.3.3.2.3.
By Symptom
9.3.3.2.4.
By End User
10.
Middle East and
Africa Opisthorchiasis Treatment Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share &
Forecast
10.2.1. By Type
10.2.2. By Diagnostic Procedure
10.2.3. By Symptom
10.2.4. By End User
10.2.5. By Country
10.3.
MEA: Country
Analysis
10.3.1. South Africa Opisthorchiasis Treatment
Market Outlook
10.3.1.1. Market Size &
Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share &
Forecast
10.3.1.2.1.
By Type
10.3.1.2.2.
By Diagnostic
Procedure
10.3.1.2.3.
By Symptom
10.3.1.2.4.
By End User
10.3.2. Saudi Arabia Opisthorchiasis Treatment
Market Outlook
10.3.2.1. Market Size &
Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share &
Forecast
10.3.2.2.1.
By Type
10.3.2.2.2.
By Diagnostic
Procedure
10.3.2.2.3.
By Symptom
10.3.2.2.4.
By End User
10.3.3. UAE Opisthorchiasis Treatment Market Outlook
10.3.3.1. Market Size &
Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share &
Forecast
10.3.3.2.1.
By Type
10.3.3.2.2.
By Diagnostic
Procedure
10.3.3.2.3.
By Symptom
10.3.3.2.4.
By End User
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Recent Development
12.2.
Mergers &
Acquisitions
12.3.
Product Launches
13.
Global Opisthorchiasis Treatment Market: SWOT Analysis
14.
Porter’s Five Forces Analysis
14.1.
Competition in the
Industry
14.2.
Potential of New
Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute
Products
15. Competitive Landscape
15.1.
Business Overview
15.2.
Service Offerings
15.3.
Recent Developments
15.4.
Key Personnel
15.5.
SWOT Analysis
15.5.1. Cipla Inc.
15.5.2. Johnson & Johnson
15.5.3. Sun Pharmaceutical Industries Ltd.
15.5.4. Merck KGaA
15.5.5. Boehringer Ingelheim International
GmbH
15.5.6. Pfizer Inc.
15.5.7. GlaxoSmithKline plc
15.5.8. F. Hoffmann-La Roche Ltd
15.5.9. AbbVie Inc
15.5.10.
Mankind Pharma Limited
16.
Strategic Recommendations
About Us & Disclaimer